Zhou R - Search Results

1

SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line.

Grover P, Nath S, Nye MD, Zhou R, Ahmad M, Mukherjee P. Grover P, et al. Among authors: zhou r. Oncotarget. 2018 Jan 5;9(6):6897-6910. doi: 10.18632/oncotarget.23966. eCollection 2018 Jan 23. Oncotarget. 2018. PMID: 29467938 Free PMC article.

2

A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.

Zhou R, Curry JM, Roy LD, Grover P, Haider J, Moore LJ, Wu ST, Kamesh A, Yazdanifar M, Ahrens WA, Leung T, Mukherjee P. Zhou R, et al. Oncogene. 2016 Oct 27;35(43):5608-5618. doi: 10.1038/onc.2015.516. Epub 2016 Jan 25. Oncogene. 2016. PMID: 26804176 Free PMC article.

3

Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors.

Moore LJ, Roy LD, Zhou R, Grover P, Wu ST, Curry JM, Dillon LM, Puri PM, Yazdanifar M, Puri R, Mukherjee P, Dréau D. Moore LJ, et al. Among authors: zhou r. Transl Oncol. 2016 Aug;9(4):295-305. doi: 10.1016/j.tranon.2016.05.001. Transl Oncol. 2016. PMID: 27567952 Free PMC article.

4

Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells.

Yazdanifar M, Zhou R, Mukherjee P. Yazdanifar M, et al. Among authors: zhou r. Curr Trends Immunol. 2016;17:95-115. Curr Trends Immunol. 2016. PMID: 28659689 Free PMC article.

5

A tumor specific antibody to aid breast cancer screening in women with dense breast tissue.

Roy LD, Dillon LM, Zhou R, Moore LJ, Livasy C, El-Khoury JM, Puri R, Mukherjee P. Roy LD, et al. Among authors: zhou r. Genes Cancer. 2017 Mar;8(3-4):536-549. doi: 10.18632/genesandcancer.134. Genes Cancer. 2017. PMID: 28680538 Free PMC article.

6

Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.

Wu ST, Fowler AJ, Garmon CB, Fessler AB, Ogle JD, Grover KR, Allen BC, Williams CD, Zhou R, Yazdanifar M, Ogle CA, Mukherjee P. Wu ST, et al. Among authors: zhou r. BMC Cancer. 2018 Apr 23;18(1):457. doi: 10.1186/s12885-018-4393-7. BMC Cancer. 2018. PMID: 29685122 Free PMC article.

7

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.

Zhou R, Yazdanifar M, Roy LD, Whilding LM, Gavrill A, Maher J, Mukherjee P. Zhou R, et al. Front Immunol. 2019 May 24;10:1149. doi: 10.3389/fimmu.2019.01149. eCollection 2019. Front Immunol. 2019. PMID: 31178870 Free PMC article.

8

Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma.

Yazdanifar M, Zhou R, Grover P, Williams C, Bose M, Moore LJ, Wu ST, Maher J, Dreau D, Mukherjee AP. Yazdanifar M, et al. Among authors: zhou r. Cells. 2019 Sep 11;8(9):1070. doi: 10.3390/cells8091070. Cells. 2019. PMID: 31514488 Free PMC article.

9

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.

Zhou R, Yazdanifar M, Roy LD, Whilding LM, Gavrill A, Maher J, Mukherjee P. Zhou R, et al. Front Immunol. 2020 Dec 7;11:628776. doi: 10.3389/fimmu.2020.628776. eCollection 2020. Front Immunol. 2020. PMID: 33365036 Free PMC article.

10

Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma.

Bose M, Grover P, Sanders AJ, Zhou R, Ahmad M, Shwartz S, Lala P, Nath S, Yazdanifar M, Brouwer C, Mukherjee P. Bose M, et al. Among authors: zhou r. Front Cell Dev Biol. 2022 Feb 14;10:821875. doi: 10.3389/fcell.2022.821875. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35237602 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,307 results

Search Page